Evidence map›Paper›PMID 30349322›Full record

ReviewInfection and drug resistance2018

Antibiotic resistance: a rundown of a global crisis.

Bilal Aslam, Wei Wang, Muhammad Imran Arshad, Mohsin Khurshid, Saima Muzammil, Muhammad Hidayat Rasool, Muhammad Atif Nisar, Ruman Farooq Alvi, Muhammad Aamir Aslam, Muhammad Usman Qamar and 2 more

Abstract readReview
In one paragraph

Review in Infection and drug resistance, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 962 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
962citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

962 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pathogens (Basel, Switzerland) · 2024
    Pooled it
  5. Article
  6. Article
  7. Article
  8. Bactericidal Activity of Eugenol-RichPathogens (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Synergistic Action of Antimicrobial Peptides and Antibiotics.International journal of molecular sciences · 2026
    Review

902 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bilal AslamDepartment of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.
Wei WangNHC Key Laboratory of Food Safety Risk Assessment, China National Center for Food Safety Risk Assessment, Beijing, China.
Muhammad Imran ArshadInstitute of Microbiology, University of Agriculture Faisalabad, Faisalabad, Pakistan.
Mohsin KhurshidDepartment of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.
Saima MuzammilDepartment of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.
Muhammad Hidayat RasoolDepartment of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.
Muhammad Atif NisarDepartment of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.
Ruman Farooq AlviDepartment of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.
Muhammad Aamir AslamInstitute of Microbiology, University of Agriculture Faisalabad, Faisalabad, Pakistan.
Muhammad Usman QamarDepartment of Microbiology, Government College University Faisalabad, Faisalabad, Pakistan.
Muhammad Khalid Farooq SalamatNeurobiology Division, The Roslin Institute, University of Edinburgh, Edinburgh, UK.
Zulqarnain BalochCollege of Veterinary Medicine, South China Agricultural University, Guangzhou, China, znbalooch@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The advent of multidrug resistance among pathogenic bacteria is imperiling the worth of antibiotics, which have previously transformed medical sciences. The crisis of antimicrobial resistance has been ascribed to the misuse of these agents and due to unavailability of newer drugs attributable to exigent regulatory requirements and reduced financial inducements. Comprehensive efforts are needed to minimize the pace of resistance by studying emergent microorganisms, resistance mechanisms, and antimicrobial agents. Multidisciplinary approaches are required across health care settings as well as environment and agriculture sectors. Progressive alternate approaches including probiotics, antibodies, and vaccines have shown promising results in trials that suggest the role of these alternatives as preventive or adjunct therapies in future.

Indexed as

alternative therapiesantibioticsevolutionmultidrug resistance

Identifiers

PMID30349322
PMCPMC6188119

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.